Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 16 10:37AM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.89 Insider Own8.15% Shs Outstand81.79M Perf Week28.72%
Market Cap353.74M Forward P/E- EPS next Y-3.57 Insider Trans-0.18% Shs Float75.12M Perf Month12.34%
Income-114.96M PEG- EPS next Q-0.79 Inst Own65.09% Short Float4.30% Perf Quarter4.47%
Sales154.06M P/S2.30 EPS this Y-94.55% Inst Trans8.91% Short Ratio3.88 Perf Half Y8.12%
Book/sh1.57 P/B2.76 EPS next Y-3.04% ROA-30.20% Short Interest3.23M Perf Year-8.56%
Cash/sh3.83 P/C1.13 EPS next 5Y- ROE-81.12% 52W Range2.01 - 6.13 Perf YTD0.82%
Dividend Est.- P/FCF- EPS past 5Y21.96% ROI-41.67% 52W High-29.45% Beta1.27
Dividend TTM- Quick Ratio4.46 Sales past 5Y38.48% Gross Margin95.05% 52W Low115.71% ATR (14)0.28
Dividend Ex-Date- Current Ratio4.46 EPS Y/Y TTM20.85% Oper. Margin-67.27% RSI (14)69.71 Volatility10.89% 8.38%
Employees302 Debt/Eq1.88 Sales Y/Y TTM106.66% Profit Margin-74.62% Recom1.20 Target Price11.67
Option/ShortYes / Yes LT Debt/Eq1.81 EPS Q/Q-11.13% Payout- Rel Volume0.82 Prev Close4.22
Sales Surprise7.75% EPS Surprise-3.08% Sales Q/Q2.64% EarningsMay 13 AMC Avg Volume833.49K Price4.32
SMA2032.66% SMA5014.90% SMA20013.36% Trades Volume146,571 Change2.49%
Date Action Analyst Rating Change Price Target Change
May-08-24Initiated BofA Securities Buy $12
Nov-09-23Initiated Deutsche Bank Buy $12
Oct-06-23Initiated Oppenheimer Outperform $10
Mar-21-23Downgrade Wells Fargo Overweight → Equal Weight $15 → $8
Aug-18-22Resumed Wells Fargo Overweight $15
Jun-18-21Initiated H.C. Wainwright Buy $35
Dec-03-20Initiated Stifel Buy $25
Sep-02-20Initiated Jefferies Buy $21
Jul-16-20Initiated Wells Fargo Overweight $18
Jan-13-20Initiated SunTrust Buy $18
Jul-09-24 08:00AM
May-19-24 09:03AM
May-13-24 09:54PM
10:00AM Loading…
May-08-24 07:17AM
Apr-30-24 08:00AM
Apr-02-24 06:18AM
Mar-26-24 09:02PM
Mar-25-24 09:53PM
Mar-21-24 09:55AM
04:36AM Loading…
Feb-28-24 04:36AM
Feb-06-24 04:05PM
Jan-04-24 04:05PM
Dec-14-23 04:05PM
Dec-11-23 04:05PM
Dec-04-23 04:05PM
Nov-27-23 04:00PM
Nov-21-23 04:05PM
Nov-13-23 05:12PM
Oct-22-23 04:25AM
Oct-16-23 04:05PM
Sep-28-23 10:17AM
Sep-19-23 08:00AM
08:00AM Loading…
Aug-30-23 08:00AM
Aug-26-23 12:57PM
Aug-17-23 08:44AM
Aug-10-23 06:05PM
Jul-12-23 12:00PM
Jun-26-23 08:00AM
Jun-21-23 04:22AM
Jun-03-23 04:00PM
May-31-23 08:00AM
May-28-23 09:37AM
May-15-23 09:15AM
May-08-23 08:00AM
May-04-23 03:52AM
May-02-23 10:02AM
May-01-23 10:01AM
Apr-27-23 04:30PM
Apr-18-23 01:30PM
Apr-17-23 07:55AM
Mar-30-23 06:45PM
Mar-17-23 04:01PM
Mar-05-23 09:17AM
Mar-01-23 08:00AM
Feb-28-23 08:00AM
Feb-17-23 04:01PM
Jan-27-23 06:31AM
Jan-10-23 09:06AM
Jan-09-23 04:05PM
Jan-06-23 01:48PM
Jan-04-23 08:00AM
Dec-21-22 08:00AM
Dec-20-22 04:05PM
Dec-17-22 07:42AM
Dec-10-22 10:30AM
Nov-23-22 07:00AM
Nov-20-22 07:07AM
Nov-11-22 09:55AM
Nov-08-22 05:45PM
Nov-03-22 09:00AM
Nov-02-22 10:00AM
Oct-24-22 07:00AM
Oct-21-22 09:55AM
Oct-05-22 09:55AM
Sep-26-22 09:39AM
Sep-19-22 11:58AM
Sep-01-22 07:00AM
Aug-29-22 09:55AM
Aug-19-22 04:01PM
Aug-11-22 09:55AM
Aug-08-22 06:05PM
Aug-03-22 07:00AM
Jul-28-22 08:07AM
Jul-26-22 04:01PM
Jul-12-22 07:00AM
Jun-29-22 11:51AM
Jun-28-22 12:25PM
Jun-27-22 07:31PM
Jun-03-22 04:01PM
Jun-02-22 07:00AM
May-14-22 08:02AM
May-09-22 05:45PM
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Srinivasan VenkateshCHIEF TECH OP OFFICERMay 01 '24Option Exercise0.002,500032,622May 03 04:21 PM
Srinivasan VenkateshCHIEF TECH OP OFFICERApr 11 '24Option Exercise0.0021,250037,704Apr 12 05:59 PM
FITZPATRICK LINDA ACHIEF PEOPLE & COMM. OFFICERMar 05 '24Option Exercise0.008,750076,060Mar 07 07:12 PM
ALBINI EDWARD CCFO AND SECRETARYMar 05 '24Option Exercise0.008,7500109,843Mar 07 04:21 PM
NEWELL WILLIAM JCEOMar 05 '24Option Exercise0.0018,7500226,893Mar 07 04:31 PM
ALBINI EDWARD CCFO AND SECRETARYMar 04 '24Option Exercise0.009,1250104,565Mar 06 04:18 PM
Chung JanePRESIDENT AND COOMar 04 '24Option Exercise0.007,875044,410Mar 06 04:21 PM
FITZPATRICK LINDA ACHIEF PEOPLE & COMM. OFFICERMar 04 '24Option Exercise0.009,125071,049Mar 06 04:25 PM
NEWELL WILLIAM JCEOMar 04 '24Option Exercise0.0031,1250219,248Mar 06 04:28 PM
NEWELL WILLIAM JCEOMar 01 '24Option Exercise0.0023,7500196,682Mar 05 04:40 PM
FITZPATRICK LINDA ACHIEF PEOPLE & COMM. OFFICERMar 01 '24Option Exercise0.006,875064,435Mar 05 04:36 PM
Srinivasan VenkateshCHIEF TECH OP OFFICERMar 01 '24Option Exercise0.005,000018,503Mar 05 04:45 PM
Chung JanePRESIDENT AND COOMar 01 '24Option Exercise0.006,875038,573Mar 05 04:32 PM
ALBINI EDWARD CCFO AND SECRETARYMar 01 '24Option Exercise0.007,875098,667Mar 05 04:29 PM
Borgman Anne ElizabethCHIEF MEDICAL OFFICERFeb 29 '24Option Exercise0.0037,500037,500Mar 04 04:15 PM
Vasquez NickiCHIEF PORT. STRAT & ALNCE OFCRJan 29 '24Option Exercise0.002,500015,303Jan 31 04:23 PM
NEWELL WILLIAM JCEOJan 29 '24Option Exercise0.0013,7500178,566Jan 31 04:29 PM
ALBINI EDWARD CCFO AND SECRETARYJan 29 '24Option Exercise0.005,250092,943Jan 31 04:28 PM
FITZPATRICK LINDA ACHIEF PEOPLE & COMM. OFFICERJan 29 '24Option Exercise0.008,250060,940Jan 31 04:25 PM
Vasquez NickiCHIEF PORT. STRAT & ALNCE OFCRJan 29 '24Sale5.0012,18560,92512,803Jan 31 04:23 PM
Shtylla BrunildaChief Business OfficerAug 28 '23Sale4.7115,42872,5950Aug 29 04:40 PM
Shtylla BrunildaChief Business OfficerAug 25 '23Sale4.5911,61353,28212,928Aug 28 04:18 PM
Chung JaneChief Commercial OfficerAug 09 '23Option Exercise0.0018,750038,181Aug 11 04:16 PM